Intellisync Corp Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
ASCO Update #2: Stock Performance Data As Of 6/8/17
Article By: Rod Raynovich
Friday, June 9, 2017 6:24 PM EDT
Biotechnology stocks are driven by clinical and deal news so here are some trends to consider.
In this article: CLVS, XBI, PUMA, KITE, BLUE, LOXO
Read
ASCO Update: Movers On The News - INCY, PBYI, RHHBY
Article By: Rod Raynovich
Tuesday, June 6, 2017 2:00 AM EDT
A lot of the product news is already “baked into” stock prices but here is a brief summary of big movers on clinical news updates. The bellwether XBI peaked at $71.72 yesterday and is down 0.62% to $70.66.
In this article: BMY, RHHBY, INCY, XBI, PUMA, BLUE
Read
ASCO Abstracts Week: Biotech Trends And Hot Stocks
Article By: Rod Raynovich
Monday, May 22, 2017 10:58 PM EDT
Today Amgen was down over 2 % on news that its osteoporosis treatment Evenity is unlikely to win FDA approval this year because of a safety risk. Radius Health was up over 6% to $37.30 as their rival drug Tymlos was approved in April.
In this article: MRK, ALNY, IBB, INCY, REGN, AMGN, CLVS, VRTX, FBT, XBI, PUMA, JUNO, EPZM, GLYC, KITE, BLUE, RDUS
Read

Latest Tweets for $PUMA

No tweets yet!